How Do We Define Cure of Diabetes?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles ( 1) and commentaries ( 2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or islet transplants, immunomodulation, bariatric/metabolic surgery) are of curative intent or have been portrayed in the media as a possible cure. However, defining remission or cure of diabetes is not as straightforward as it may seem. Unlike “dichotomous” diseases such as many malignancies, diabetes is defined by hyperglycemia, which exists on a continuum and may be impacted over a short time frame by everyday treatment or events (medications, diet, activity, intercurrent illness). The distinction between successful treatment and cure is blurred in the case of diabetes. Presumably improved or normalized glycemia must be part of the definition of remission or cure. Glycemic measures below diagnostic cut points for diabetes can occur with ongoing medications (e.g., antihyperglycemic drugs, immunosuppressive medications after a transplant), major efforts at lifestyle change, a history of bariatric/metabolic surgery, or ongoing procedures (such as repeated replacements of endoluminal devices). Do we use the terms remission or cure for all patients with normal glycemic measures, regardless of how this is achieved?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies [54–57] subdivided results as previously proposed by Buse et al. [58].”
The cited source says what the claim attributes to it.
In the citing paper
“Sustained improvements over two years were observed with high (74 %) retention, of whom 19 % achieved remission by the definition of Buse et al. [1] and 25 % according to the Riddle et al. 2021 international consensus definition [2].”
The cited source says what the claim attributes to it.
In the citing paper
“Firstly, the definition of remission of diabetes is the subject of considerable debate, specifically with regards to threshold levels of HbA1c/fasting glucose, use of diabetes medication, and the length of follow-up time meeting these criteria.60”
In the citing paper
“The Look AHEAD Trial, the Diabetes Remission Clinical Trial (DiRECT) and the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) highlighted the potential for T2DM remission, defined as the maintenance of euglycemia (complete remission) or prediabetes level of glycemia (partial remission) with no diabetes medication for at least 1 year, with a weight loss of 15 kg or more”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundCan Diabetes Be Cured? Potential Biological and Mechanical Approaches
Saudek, C. D. (2009) · JAMA · doi:10.1001/jama.2009.508 · Cited by 26 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundBarnes, E. (2007) · Chronic Illness · doi:10.1177/1742395307085333 · Cited by 17
Cited by
Items 301–400 of 1,000
Perugini, R. A., & Malkani, S. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283446c1f · Cited by 31
Long-term outcome of laparoscopic sleeve gastrectomy from a single center in mainland China
Hans, P. K., Guan, W., Lin, S., & Liang, H. (2017) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2017.04.003 · Cited by 35
Still, C. D., Benotti, P. N., Mirshahi, T., Cook, A., & Wood, G. C. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.12.020 · Cited by 31
Churuangsuk, C., Lean, M. E. J., & Combet, E. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120000105 · Cited by 35
“There have been debates on the definitions of remission of T2D((105,106)).”
BackgroundZerrweck, C., Herrera-González, A., Sepúlveda, E. M., Rodríguez, F. M., & Guilbert, L. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.03.030 · Cited by 31
Consensus report: Definition and interpretation of remission in type 2 diabetes
Riddle, M. C., Cefalu, W. T., Evans, P. H., Gerstein, H. C., Nauck, M. A., Oh, W. K., Rothberg, A. E., le Roux, C. W., Rubino, F., Schauer, P. R., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14669 · Cited by 39
Self-citationNot Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus
Kim, J., & Kwon, H. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0377 · Cited by 33
“Therefore, expert consensus introduced the concept of remission as a common term to express this phenomenon in 2009 [13].”
BackgroundRamos-Levi, A. M., Sánchez-Pernaute, A., Matía‐Martín, P., Cabrerizo, L., Barabash, A., Hernandez, C., Calle‐Pascual, A. L., Torres, A., & Rubio, M. Á. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0995-y · Cited by 33
“001), based on previous [2] and 2009 consensus criteria [8] Table 2 Crude odds ratios (OR) and 95 % confidence intervals (CI) of preoperative characteristics and %EWL for prediction of T2D remission”
BackgroundMethodInfluentialAuclair, A., Martin, J., Bastien, M., Bonneville, N., Biertho, L. D., Marceau, S., Hould, F., Biron, S., Lebel, S., Lescelleur, O., et al. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1973-3 · Cited by 31
Does bariatric surgery prevent progression of diabetic retinopathy?
Chen, Y., Laybourne, J. P., Sandinha, T., de Alwis, N. M. W., Avery, P. J., & STEEL, D. H. (2017) · Eye · doi:10.1038/eye.2017.119 · Cited by 31
Hong, J., Park, S. S., Menzo, E. L., & Rosenthal, R. J. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.11.021 · Cited by 33
Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus
Kota, S., Ugale, S. M., Gupta, N., Naik, V., Kumar, K. V. S. H., & Modi, K. D. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.98017 · Cited by 32
Tharakan, G., Scott, R., Szepietowski, O., Miras, A. D., Blakemore, A. I. F., Purkayastha, S., Ahmed, A. R., Chahal, H., & Tan, T. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2368-9 · Cited by 31
“Remission of diabetes was defined as per the American Diabetes Association (ADA) criteria [11].”
Piché, M., Clavel, M.-A. A., Auclair, A., Rodríguez-Flores, M., O’Connor, K., Garceau, P., Rakowski, H., & Poirier, P. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154773 · Cited by 32
Visceral Obesity Is a Negative Predictor of Remission of Diabetes 1 Year After Bariatric Surgery
Kim, M. K., Lee, H. H., Kwon, H., Baek, K., Kim, E. K., Lee, K. W., & Song, K. (2011) · Obesity · doi:10.1038/oby.2011.205 · Cited by 30
Rubio, M. Á., Monereo, S., Lecube, A., Resa, J., Masdevall, C., Vigó, F. D. L. C., Garrido, M., Goday, A., Llorente, I., & Pesquera, C. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.10.002 · Cited by 30
Indikation und Prinzipien der metabolischen Chirurgie
Weiner, R. A. (2010) · Der Chirurg · doi:10.1007/s00104-009-1859-9 · Cited by 36
Sepúlveda, M., Alamo, M., Preiss, Y., & Valderas, J. P. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3402-x · Cited by 32
Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes
Guarino, D., Moriconi, D., Mari, A., Rebelos, E., Colligiani, D., Baldi, S., Anselmino, M., Ferrannini, E., & Nannipieri, M. (2018) · Diabetologia · doi:10.1007/s00125-018-4737-5 · Cited by 32
Lei, S., Huang, F., Zhao, A., Chen, T., Chen, W., Xie, G., Zheng, X., Zhang, Y., Yu, H., Zhang, P., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700055r · Cited by 30
“0 mM for 1 yr or more without active pharmacological intervention (15).”
BackgroundDiabetes remission and relapse after bariatric surgery: a nationwide population-based study
Conte, C., Lapeyre-Mestre, M., Hanaire, H., & Ritz, P. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04924-3 · Cited by 29
Why prescribe exercise as therapy in type 2 diabetes? We have a pill for that!
Ried‐Larsen, M., MacDonald, C. S., Johansen, M. Y., Hansen, K. B., Christensen, R., Almdal, T. P., Pedersen, B. K., & Karstoft, K. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2999 · Cited by 29
“In this regard, we also need to establish the minimal exercise dosage that will directly affect the pathophysiological mechanisms leading to vascular disease, beta‐cell function, and/or induce prolonged T2D remission.(55) Additionally, to establish efficacy on clinically relevant and reliable endpoints and explore exe…”
BackgroundBagnasco, D., Bondi, B., Caminati, M., Nicola, S., Pini, L., Milanese, M., Brussino, L., Senna, G., Canonica, G. W., & Braido, F. (2024) · Biomedicines · doi:10.3390/biomedicines12050960 · Cited by 31
Effect of Bariatric Surgery Versus Intensive Medical Management on Diabetic Ophthalmic Outcomes
Singh, R. P., Gans, R., Kashyap, S. R., Bedi, R., Wolski, K., Brethauer, S. A., Nissen, S. E., Bhatt, D. L., & Schauer, P. (2015) · Diabetes Care · doi:10.2337/dc14-2035 · Cited by 29
“6 mmol/L) without glucoselowering medication for at least 1 year after bariatric surgery (2).”
BackgroundBanded Versus Nonbanded Sleeve Gastrectomy: A Randomized Controlled Trial With 3 Years of Follow-up
Fink, J. M., Hetzenecker, A., Seifert, G. J., Runkel, M., Laessle, C., Fichtner‐Feigl, S., & Marjanović, G. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004174 · Cited by 31
“Diabetes remission was defined as normal glycemic measurements of at least 1-year duration in absence of antidiabetic medication.(14) Improvement was defined as relevant reduction in HbA1c not meeting criteria for remission.”
Jans, A., Szabó, É., Näslund, I., Ottosson, J., Näslund, E. B., & Stenberg, E. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.12.005 · Cited by 29
“However, we believe that the vast majority of patients treated preoperatively for T2D are likely to be followed up with vigilance in healthcare, not least due to a general distrust of definitive cure of chronic disease [32].”
BackgroundType 2 Diabetes Remission with Significant Weight Loss: Definition and Evidence-Based Interventions
Ko, J. H., & Kim, T. N. (2022) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes22001 · Cited by 31
Favennec, M., Hennart, B., Verbanck, M., Pigeyre, M., Caiazzo, R. J., Raverdy, V., Verkindt, H., Leloire, A., Guillemin, G. J., Yengo, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158051 · Cited by 32
Du, X., Zhou, H., Zhang, S., Tian, H., Zhou, Z., & Cheng, Z. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.08.499 · Cited by 31
One-year impact of bariatric surgery on serum anti-Mullerian-hormone levels in severely obese women
Vincentelli, C., Maraninchi, M., Valéro, R., Béliard, S., Maurice, F., Emungania, O., Berthet, B., Lombard, E., Dutour, A., Gaborit, B., et al. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1196-3 · Cited by 62
Yang, J. Z., Feng, X., Zhong, S.-Z., Wang, Y., & Liu, J. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1135-4 · Cited by 29
The Great Debate: Medicine or Surgery
Lautz, D. B., Halperin, F., GOEBEL-FABBRI, A. E., & Goldfine, A. B. (2011) · Diabetes Care · doi:10.2337/dc10-1859 · Cited by 31
Jeevanandam, J., Chan, Y. S., & Danquah, M. K. (2020) · 3 Biotech · doi:10.1007/s13205-020-02480-2 · Cited by 28
Single Anastomosis Sleeve Ileal Bypass (SASI Bypass): Short-Term Outcomes and Concerns
Romero, R. J., Colorado-Subizar, R., Uriarte-Lorente, M. D., Barradas-Lagunes, M., Ávila, P. B.-D., & Romero-Espejo, J. J. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05145-4 · Cited by 28
Pullman, J. S., Plank, L. D., Nisbet, S., Murphy, R., & Booth, M. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06635-x · Cited by 31
“0% without diabetic medications to define remission, in accord with the consensus definition of remission at the time of the trial protocol publication [17].”
ResultFaucher, P., Poitou, C., Carette, C., du Montcel, S. T., Barsamian, C., Touati, E.-B., Bouillot, J., Torcivia, A., Czernichow, S., Oppert, J., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2106-3 · Cited by 29
“complete remission of diabetes were defined according to American Diabetes Associa t ion cr i ter ia [20] by HbA1C ≤ 6.”
MethodBình, T. Q., Phương, P. T., & Nhung, B. T. (2015) · Rural and Remote Health · doi:10.22605/rrh3275 · Cited by 28
Murphy, R., Evennett, N. J., Clarke, M., Robinson, S. J., Humphreys, L., Jones, B., Kim, D. D., Cutfield, R. G., Plank, L. D., Hammodat, H., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011416 · Cited by 29
“literature with distinct thresholds of HbA1c and fasting glucose, generally in the absence of glucose lowering therapy, to represent varying degrees of diabetes improvement.(10) However, these are controversial given that the diagnosis of diabetes itself is not dichotomous and rather thresholds of glycaemia have been…”
BackgroundFatty Acid Metabolic Remodeling During Type 2 Diabetes Remission After Bariatric Surgery
Grenier–Larouche, T., Carreau, A., Géloën, A., Frisch, F., Biertho, L. D., Marceau, S., Lebel, S., Hould, F., Richard, D., Tchernof, A., et al. (2017) · Diabetes · doi:10.2337/db17-0414 · Cited by 29
“Patients included in our study lost almost all of their excess weight over the first year after DS and all T2D patients were in partial or complete remission (28) three months after the intervention.”
BackgroundInfluentialCardinelli, C. D. S., Torrinhas, R. S., Sala, P., Pudenzi, M. A., Angolini, C. F. F., da Silva, M. M., Machado, N. M., Ravacci, G. R., Eberlin, M. N., & Waitzberg, D. L. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.028 · Cited by 29
Media Reinforcement for Psychological Empowerment in Chronic Disease Management
Ghosh, K., Khuntia, J., Chawla, S. K., & Deng, X. (2014) · Communications of the Association for Information Systems · doi:10.17705/1cais.03422 · Cited by 30
Jeon, S., Lee, S., Kim, E. H., Eun, J., Lee, K., Lim, H., & Lee, J. (2025) · JMIR Formative Research · doi:10.2196/72553 · Cited by 28
“Diabetes mellitus, a chronic condition caused by insufficient insulin production or usage [1-5], requires vigilant daily self-management to prevent complications such as cardiovascular disease, neuropathy, nephropathy, and retinopathy [1,3,6,7].”
Torres, A. J., & Rubio, M. Á. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0357 · Cited by 27
“Adapted from Buse et al. (26). Post-bariatric management guideline 173 EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011) 165”
BackgroundMin, T., Prior, S. L., Churm, R., Dunseath, G. J., Barry, J. D., & Stephens, J. W. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04116-8 · Cited by 29
Kwon, Y., Lee, S., Kim, D., ALRomi, A., Park, S., Lee, C. M., Kim, J.-H., & Park, S. S. (2022) · Diabetes Care · doi:10.2337/dc22-0835 · Cited by 31
Luca, M. D., Zappa, M. A., Zese, M., Bardi, U., Carbonelli, M. G., Carrano, F. M., Casella, G., Chianelli, M., Chiappetta, S., Iossa, A., et al. (2022) · Nutrients · doi:10.3390/nu15010189 · Cited by 27
Liberale, L., Bonaventura, A., Carbone, F., Bertolotto, M. B., Contini, P., Scopinaro, N., Camerini, G. B., Papadia, F. S., Cordera, R., Camici, G. G., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.044 · Cited by 30
Garg, H., Aggarwal, S., Misra, M. C., Priyadarshini, P., Swami, A., Kashyap, L., & Jaiswal, R. (2017) · International Journal of Surgery · doi:10.1016/j.ijsu.2017.10.076 · Cited by 27
Outcomes After Metabolic Surgery in Asians—a Meta-analysis
Yeo, D. X. W., Yeo, C., Low, T. Y., Ahmed, S., Phua, S. S. H., Oo, A. M., Rao, J., Koura, A. N., Venkataraman, K., & Sanghvi, K. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3484-5 · Cited by 27
Ser, K., Lee, W., Chen, J., Tsai, P.-L., Chen, S., & Lee, Y.-C. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.11.020 · Cited by 27
MEHRA, C. G., Raymond, A. M., & Prabhu, R. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01212-2 · Cited by 26
“Additionally, 100% of participants achieved a mean FBS level of < 126 mg/ dL, which is the cut-off for partial remission of diabetes [13].”
BackgroundGrenier–Larouche, T., Carreau, A., & Carpentier, A. C. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.10.013 · Cited by 27
Heshmati, K., Harris, D. A., Aliakbarian, H., Tavakkoli, A., & Sheu, E. G. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.04.004 · Cited by 27
Friedman, A. N., Wang, J., Wahed, A. S., Docherty, N. G., Fennern, E. B., Pomp, A., Purnell, J. Q., le Roux, C. W., & Wolfe, B. M. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.05.013 · Cited by 29
Insulin sensitivity and secretion modifications after bariatric surgery.
Castagneto‐Gissey, L., & Mingrone, G. (2012) · PubMed · doi:10.3275/8470 · Cited by 29
McKenzie, A. L., Athinarayanan, S. J., Van Tieghem, M. R., Volk, B. M., Roberts, C. G. P., Adams, R. N., Volek, J. S., Phinney, S. D., & Hallberg, S. J. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111898 · Cited by 25
Miras, A. D., Risstad, H., Baqai, N., Law, S., Søvik, T. T., Mala, T., Olbers, T., Kristinsson, J. A., & le Roux, C. W. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12177 · Cited by 26
“Considering the need for uniform and validated tools for assessment of outcomes after bariatric surgery, an American Diabetes Association (ADA) expert panel was the first to define ‘complete’ and ‘partial’ remission, which incorporated fasting glucose, glycated haemoglobin (HbA1c) and use of glucose-lowering medicatio…”
BackgroundKam, H., Tu, Y., Pan, J., Han, J., Zhang, P., Bao, Y., & Yu, H. (2020) · Obesity Surgery · doi:10.1007/s11695-019-04371-9 · Cited by 27
Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist’ s perspective
Sonali, G., Hong, C., Phong, C., & Tham, K. W. (2015) · Journal of Biomedical Research · doi:10.7555/jbr.29.20140127 · Cited by 26
“These studies confirm that bariatric surgery is indeed more effective than medical management of T2DM [7-9] .”
BackgroundGlucose Variability After Bariatric Surgery: Is Prediction of Diabetes Remission Possible?
Ramos-Levi, A. M., Sánchez-Pernaute, A., Marcuello, C., Galindo, M., Calle‐Pascual, A. L., Torres, A. J., & Rubio, M. Á. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2960-7 · Cited by 25
Bonaventura, A., Liberale, L., Carbone, F., Vecchié, A., Bonomi, A., Scopinaro, N., Camerini, G. B., Papadia, F. S., Maggi, D. C., Cordera, R., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01345-2 · Cited by 26
Ilyas, S., Al-Refai, R., Maharjan, R., Bustamante, L. D., Ghattas, K. N., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.9973 · Cited by 38
“The complete remission criteria set by the ADA are fasting plasma glucose (FPG) <100 mg/dL and HbA1c <6%, without the use of any hypoglycemic medication for one year [38].”
BackgroundArterburn, D. E., Campos, G. M., Haneuse, S., Sherwood, N. E., Bogart, A., Sidney, S., Coleman, K. J., Theis, M. K., O’Connor, P. J., & Fisher, D. P. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0960-9 · Cited by 25
Zhu, Z., Shan, X., Cheng, Y., Xu, J., Fu, H., Wang, W., Yan, R., & Cai, Q. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1426-4 · Cited by 26
“Unchanged was defined as no postoperative change, and worse was defined as an aggravation in the FBG level and medication requirement after surgery [9–13].”
BackgroundNicholas, A. P., Soto-Mota, A., Lambert, H., & Collins, A. L. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.67 · Cited by 25
“The American Diabetes Association (ADA) defines three states of remission: (1) ‘partial’ – subdiabetic hyperglycaemia [glycated haemoglobin (HbA1c) 5⋅7–6⋅4 %] for at least 1 year; (2) ‘complete’ – normoglycaemic (HbA1c level <5⋅7 %) for at least 1 year; (3) ‘prolonged’ – complete remission for at least 5 years((6)).”
BackgroundChen, Y., Zeng, G., Tan, J., Tang, J., Ma, J., & Rao, B. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2622 · Cited by 25
“7% and FPG levels of 100 mg/dL or less per the American Diabetes Association guidelines [14].”
BackgroundKim, M. K., Jang, E.-H., Hong, O., Chun, H., Yoo, S.-J., Baek, K., Kim, W., Kim, E. K., Song, K., & Kwon, H. (2013) · International Journal of Endocrinology · doi:10.1155/2013/681205 · Cited by 24
“Mee Kyoung Kim,1 Eun-Hee Jang,2 Oak-Kee Hong,1 Hyun-Ji Chun,1 Soon-Jib Yoo,1 Ki-Hyun Baek,1 Wook Kim,3 Eung Kook Kim,3 Ki-Ho Song,1 and Hyuk-Sang Kwon1 1 Department of Internal Medicine, Yeouido St. Mary’s Hospital, The Catholic University of Korea, 62 Yeouido-dong Youngdeungpo-gu, Seoul 150-713, Republic of Korea 2De…”
InfluentialJi, G., Li, P., Li, W., Sun, X., Yu, Z., Li, R., Zhu, L., & Zhu, S. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03861-0 · Cited by 25
Sala, P., Torrinhas, R. S., Fonseca, D. C., Heymsfield, S. B., Giannella‐Neto, D., & Waitzberg, D. L. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2602-0 · Cited by 23
“T2Dr Assessment Patients were followed for 1 year after RYGB to identify T2Dr according to the ADA criteria [4], which define complete T2Dr as HbA1c <6% (<42 mmol/ mol) and fasting glucose (FG) <100 mg/dL (5.”
MethodElectrophotonic Imaging Based Analysis of Diabetes
Shiva Kumar, K. (2016) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2016.04.00134 · Cited by 23
Yu, Z., Li, P., Li, P., Zhang, H., & Zhang, Y. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05692-4 · Cited by 26
Bariatric Surgery: Prevalence, Predictors, and Mechanisms of Diabetes Remission
Argyropoulos, G. A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0590-9 · Cited by 23
Felici, A. C., Lambert, G., Lima, M. M. D. O., Pareja, J. C., Rodovalho, S., Chaim, É. A., & Geloneze, B. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1377-9 · Cited by 23
“Diabetes remission was defined according to the recommendation of the American Diabetes Association [15].”
MethodBusetto, L., Stefano, F. D., Pigozzo, S., Segato, G., Luca, M. D., & Favretti, F. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.03.010 · Cited by 23
Rasmussen‐Torvik, L. J., Almoguera, B., Doheny, K. F., Freimuth, R. R., GORDON, A. S., Hakonarson, H. H., Hawkins, J. B., Husami, A., Ivacic, L. C., Kullo, I. J., et al. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.04.002 · Cited by 23
“998.(8) Orthogonal clinical genotyping platforms included the Illumina ADME array, custom Agena Bioscience (San Diego, CA; previously Sequenom) genotyping panels, commercial Agena Bioscience ADME genotyping panels, Sanger sequencing, TaqMan-based genotyping arrays, and custom PCR-based assays.”
MethodFeng, W., Yin, T., Chu, X., Shan, X., Jiang, C., Wang, Y., Qian, Y., Zhu, D., Sun, X., & Bi, Y. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3138 · Cited by 24
Schmidt, M. I., Bracco, P. A., Canhada, S., Guimarães, J. M. N., Barreto, S. M., Chor, D., Griep, R. H., Yudkin, J. S., & Duncan, B. B. (2020) · Diabetes Care · doi:10.2337/dc20-2030 · Cited by 23
“being complete (to normal glycemia by all threeglycemic tests) or incomplete (to IH, but no longer meeting diabetes criteria by any of the three glycemic tests) (18).”
BackgroundAngrisani, L., Ferraro, L., Santonicola, A., Palma, R., Formisano, G., & Iovino, P. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.11.028 · Cited by 25
Preoperative bariatric surgery predictors of type 2 diabetes remission
Fultang, J., Chinaka, U., Rankin, J., Bakhshi, A., & Ali, A. (2021) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20084 · Cited by 22
Zachariah, P. J., Chen, C.-Y., Lee, W., Chen, S.-C., Ser, K., Chen, J., & Lee, Y.-C. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2205-1 · Cited by 23
Wu, T., Wong, S. K., Law, B. T. T., Grieve, E., Wu, O., Tong, D. K. H., Leung, D. K. W., Lam, C. L. K., & Wong, C. K. H. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3236 · Cited by 23
Type 2 diabetes: multimodal treatment of a complex disease
Pournaras, D. J., & le Roux, C. W. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00132-4 · Cited by 22
Association of DiaRem Score With Cure of Type 2 Diabetes Following Bariatric Surgery
Wood, G. C., Mirshahi, T., Still, C. D., & Hirsch, A. G. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.0251 · Cited by 22
Chong, K., Ikramuddin, S., Lee, W., Billington, C. J., Bantle, J. P., Wang, Q., Thomas, A. J., Connett, J. E., Leslie, D. B., Inabnet, W. B., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2433-4 · Cited by 24
Ke, Z., Li, F., Chen, J., Gao, Y., Zhou, X., Sun, F., Li, C., Liu, B., Li, Q., Zhu, Z., et al. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2926-9 · Cited by 23
Davé, R., Davis, R., & Davies, J. S. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.01.005 · Cited by 24
de Hoogh, I. M., Oosterman, J. E., Otten, W., Krijger, A.-M., Berbée, S., Pasman, W. J., van Ommen, B., Pijl, H., & Wopereis, S. (2021) · Nutrients · doi:10.3390/nu13072193 · Cited by 27
One Anastomosis Gastric Bypass Versus Long Biliopancreatic Limb Roux-en-Y Gastric Bypass
Ibrahim, M. Y., Elshennawy, A. S., Wassef, A. T. S., Salah, A., Hassan, A. M., & Mikhail, S. A. (2022) · Obesity Surgery · doi:10.1007/s11695-021-05874-0 · Cited by 23
Sala, P., Torrinhas, R. S., Fonseca, D. C., Machado, N. M., Singer, J., Singer, P., Ravacci, G. R., Belarmino, G., Ferreira, B. D. A. M., Marques, M. Q., et al. (2020) · Nutrition · doi:10.1016/j.nut.2020.110885 · Cited by 21
Molecular Insights on the Therapeutic Effect of Selected Flavonoids on Diabetic Neuropathy
Prabhawathi, V., Sivakumar, P. M., Prabhakar, P. K., Çetinel, S., & Neelakandan, R. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220309140855 · Cited by 21
Feasibility of Amylin Imaging in Pancreatic Islets with β-Amyloid Imaging Probes
Yoshimura, M., Ono, M., Watanabe, H., Kimura, H., & Saji, H. (2014) · Scientific Reports · doi:10.1038/srep06155 · Cited by 21
Adams, T. D., Davidson, L. E., Litwin, S. E., & Hunt, S. C. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0286-4 · Cited by 24
Roux-en-Y Gastric Bypass Could Slow Progression of Retinopathy in Type 2 Diabetes: A Pilot Study
Banks, J., Adams, S. T., Laughlan, K., Allgar, V. L., Miller, G. V., Jayagopal, V., Gale, R. P., Sedman, P. C., & Leveson, S. H. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1476-7 · Cited by 21
“6 mmol/l, measured at least 1 year after surgery, without the use of diabetic medication [27].”
BackgroundAdami, G. F., Gradaschi, R., Andraghetti, G., Scopinaro, N., & Cordera, R. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2126-z · Cited by 23
Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion
Scopinaro, N., Adami, G. F., Bruzzi, P., & Cordera, R. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2555-3 · Cited by 21
The impact of bariatric surgery on insulin-treated type 2 diabetes patients
Lemus, R., Karni, D., Hong, D., Gmora, S. B., Breau, R., & Anvari, M. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5777-5 · Cited by 21
Kim, J., Huh, Y., Park, S., Park, Y. S., Park, D. J., Kwon, J., Lee, J. H., Heo, Y. S., & Choi, S. H. (2019) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2019.03.018 · Cited by 22
“Diabetes resolution and improvement were evaluated following American Diabetes Association criteria.(6) Complete remission was defined as FBS level <100 mg/dL and HbA1c level <6.”
MethodLee, M.-H., Almalki, O. M., Lee, W., Chen, S., Chen, J., & Wu, C. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04737-4 · Cited by 21
Cui, B., Wang, G., Li, P., Li, W., Zhu, L., & Zhu, S. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.03.001 · Cited by 23
Adam, S., Liu, Y., Siahmansur, T. J., Ho, J. H., Dhage, S. S., Yadav, R., New, J. P., Donn, R. P., Ammori, B. J., Syed, A. A., et al. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119826479 · Cited by 21
Metadata
- Authors
- Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., Kahn, R., & Kirkman, M. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Pennington Biomedical Research Center (US)
- University of Warwick (GB)
- Department of Endocrinology & Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy;
- University of Nebraska–Lincoln (US)
- University of Rochester Medicine (US)
- Pacific Northwest Research Institute (US)
- NewYork–Presbyterian Hospital (US)
- American Diabetes Association (US)
- Corresponding author
- Kirkman, M. Sue
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2133-2135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768219
- OpenAlex
- W2138592519
- Cited by
- 1,003
- References
- 3
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 38 · 2023: 46 · 2022: 74 · 2021: 85 · 2020: 101 · 2019: 90 · 2018: 78 · 2017: 85 · 2016: 78 · 2015: 66 · 2014: 57 · 2013: 63 · 2012: 46
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes cure, diabetes remission, glycemic control, hyperglycemia, type 1 diabetes, type 2 diabetes, islet transplantation, pancreas transplantation, bariatric surgery, metabolic surgery, immunomodulation
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Health Status, Humans, Reference Values, Remission Induction, Societies, Medical, United States, Genetic Predisposition to Disease, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.